BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Johnson & Johnson 

1 Johnson & Johnson Plaza

New Brunswick  New Jersey  08933  U.S.A.
Phone: 732-524-0400 Fax: 732-524-3300


SEARCH JOBS


Industry
Pharmaceutical


Collaborations

Alliance Pharmaceutical Corp.  Oxygent ™ co-development

Medarex, Inc.  Broad HuMAb-Mouse antibody development agreement.

Incyte Corporation 

Genetronics, Inc.  On October 6, 1998 Genetronics entered into comprehensive development and license agreements involving its proprietary drug delivery system for Electroporation Therapy treatment of cancer with Ethicon, Inc., a Johnson & Johnson company

Essential Therapeutics, Inc.   Cephalosporin which is currently in pre-clinical stages - and will target Staphylococcal infections, Enterococcal infections, and Streptococcus pneumoniae infections.

Pharmagene Laboratories Limited 

Bristol-Myers Squibb Company 

Amersham Biosciences 

PanVera LLC 

Rigel Pharmaceuticals, Inc. 

Massachusetts Life Sciences Center 





 Company News
Johnson & Johnson (JNJ) to Buy Aragon Pharmaceuticals, Inc. for Up to $1 Billion 6/17/2013 7:06:06 AM    More...
Johnson & Johnson (JNJ) Sells Final Stake in Elan Corporation PLC (ELN) for $332 Million 6/14/2013 7:55:50 AM    More...
Johnson & Johnson (JNJ) Unit, Cordis Corporation (JNJ) Gets FDA OK for Advanced Guiding Catheter 6/13/2013 6:43:14 AM    More...
Johnson & Johnson (JNJ) Release: David Julius Wins 2013 Dr. Paul Janssen Award for Biomedical Research 6/12/2013 1:38:50 PM    More...
Johnson & Johnson (JNJ) Recalls Benecol Over Yeast Fermentation Concerns 6/7/2013 8:00:42 AM    More...
Johnson & Johnson (JNJ)'s Orthopedic Biz Head: We are Still Struggling With the Integration of Synthes, Inc. (SYST) a Year Later 6/6/2013 7:53:21 AM    More...
Johnson & Johnson (JNJ) Expands Footprint in SF; Aims to Hatch Startups, Breakthrough Innovations 6/5/2013 8:24:22 AM    More...
Second Genome Gets Johnson & Johnson (JNJ) Deal, $6.5 Million, to Delve Into Bugs in the Gut 6/5/2013 7:04:23 AM    More...
Johnson & Johnson (JNJ) Recalls 32 Million Boxes of Contraceptives From 43 Countries 6/4/2013 7:14:48 AM    More...
Protagonist Therapeutics Pulls in $14 Million, Led by Johnson & Johnson (JNJ), for Peptide Pills 6/4/2013 7:08:11 AM    More...
12345678910...